"Designing Growth Strategies is in our DNA"
According to American Cancer Society, from 1989 to 2015, the U.S. witnessed 39% reduction in mortality rate of patients suffering from breast cancer and in 2017, there were an estimated 3.1 million breast cancer survivors in the U.S. These statistics are a result of early diagnosis of breast abnormalities.
The Breast Imaging technique is used in the diagnosis of breast-related abnormalities such as fibrocystic breast changes, fibroadenomas, blocked milk ducts, intraductal papillomas, cysts, and others. These breast imaging technologies are used by physicians and oncology surgeons in order to perform diagnosis of breast structure, cells composition, lumps, and other internal parts of the breast. Breast imaging has played a major role in detecting cancer cells and lumps even before they are felt to bare hands, which has led to a reduction in the mortality rate of breast-related disorders worldwide.
To gain extensive insights into the market, Request for Customization
Increasing awareness about breast health is one of the prominent drivers for the growth of the global breast imaging market. In October 2018, DenseBreast-info.org broadcasted three informational videos worldwide to educate women about breast density and its implications on breast health. This combined with the growing demand of improved breast diagnosis, increasing prevalence of breast cancer, improved care processes, and prolonged life expectancy of cancer survivors due to proper treatment and accurate diagnosis are factors driving the growth of the global breast imaging market.
Stringent government regulations and increased risk of radiation exposure are expected to hamper the growth of the global breast imaging market during the forecast period. Combined with this, higher acquisition and maintenance cost of breast imaging equipment is also projected to slow the growth of the breast imaging market, especially in emerging nations.
Some of the major companies that are present in the global breast imaging market are GENERAL ELECTRIC COMPANY, Siemens Ltd., Koninklijke Philips N.V., Hologic Inc., FUJIFILM Holdings Corporation, SonoCiné, Dilon Technologies, Inc., CMR Naviscan, Thorlabs, Inc., Barco, DUNE, and others.
SEGMENTATION | DETAILS |
By Imaging Modality | · Breast MRI · Mammography · Breast Tomosynthesis · Galactography · Scinti-mammography · Others |
By End User | · Hospitals · Ambulatory Surgery Centres · Diagnostic Centres · Cancer Care Centres · Others |
By Geography | · North America (USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
Among the imaging modality segments, breast tomosynthesis is anticipated to register comparatively higher share in the global breast imaging market owing to superior image acquisition because of the integration of intelligent algorithms.
North America is expected to dominate the global breast imaging market owing to increasing awareness about the early diagnosis of breast cancer and enhanced diagnostic technologies. Asia Pacific and Middle East & Africa regions hold huge potential for global breast imaging market owing to the prevalence of breast disorders in African countries, the rise in awareness about breast disorders by Non-Governmental Organizations and women & child care departments of national governments, and a large undiagnosed patient population in the regions.
US +1 833 909 2966 ( Toll Free )